|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-6-12
|
|
pubmed:abstractText |
This safety study of terameprocol (also called M4N, EM-1421) daily vaginal application in healthy women explores its potential application as a microbicide in interrupting human immunodeficiency virus sexual transmission and additional interruption of human papillomavirus and herpes simplex virus transmission.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0148-5717
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
577-82
|
|
pubmed:dateRevised |
2008-9-9
|
|
pubmed:meshHeading |
pubmed-meshheading:18418294-Administration, Intravaginal,
pubmed-meshheading:18418294-Adult,
pubmed-meshheading:18418294-Animals,
pubmed-meshheading:18418294-Antiviral Agents,
pubmed-meshheading:18418294-Double-Blind Method,
pubmed-meshheading:18418294-Female,
pubmed-meshheading:18418294-Humans,
pubmed-meshheading:18418294-Nordihydroguaiaretic Acid,
pubmed-meshheading:18418294-Ointments,
pubmed-meshheading:18418294-Rabbits,
pubmed-meshheading:18418294-Sexually Transmitted Diseases, Viral,
pubmed-meshheading:18418294-Treatment Outcome,
pubmed-meshheading:18418294-Vagina
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Phase I clinical trial of repeat dose terameprocol vaginal ointment in healthy female volunteers.
|
|
pubmed:affiliation |
Department of Family and Community Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. nkhanna@umaryland.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
